U.S. federal trademark · Serial No. 98044278
Research and development of therapeutic drugs for the treatment of cancer, immune inflammatory diseases, and autoimmune diseases; research and development of therapeutic antibodies and pharmaceuticals; research and development of technology in the field of therapeutic antibodies, pharmaceuticals and biopharmaceuticals; development of pharmaceutical preparations and medicines; pharmaceutical drug development services and drug discovery services; medical research for development of therapeutic modalities for treatment of diseases
Pharmaceutical and medical preparations for the treatment of cancer, immune inflammatory diseases, and autoimmune diseases; pharmaceutical therapeutics for the treatment of cancer, immune inflammatory diseases, and autoimmune diseases; protein degraders being pharmaceutical preparations for the treatment of cancer, immune inflammatory diseases, and autoimmune diseases
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.